TickerFacts.

ENANTA PHARMACEUTICALS INC (ENTA) — Operating Income

Annual figures by period end, from SEC filings.

2011-09-30: $25.30M2012-09-30: $21.29M2013-09-30: $9.03M2014-09-30: $18.98M2015-09-30: $124.15M2016-09-30: $30.84M2017-09-30: $24.61M2018-09-30: $88.33M2019-09-30: $36.74M2020-09-30: -$41.64M2021-09-30: -$109.57M2022-09-30: -$123.84M2023-09-30: -$137.21M2024-09-30: -$121.69M2025-09-30: -$85.35M-$85.35M
2011-09-30Operating Income (USD)2025-09-30
Period endedOperating IncomeChange YoYSource filing
2025-09-30-$85.35M—2025-11-19From 2024-10-01
2024-09-30-$121.69M—2025-11-19From 2023-10-01
2023-09-30-$137.21M—2025-11-19From 2022-10-01
2022-09-30-$123.84M—2024-11-27From 2021-10-01
2021-09-30-$109.57M—2023-11-22From 2020-10-01
2020-09-30-$41.64M-213.3%2022-11-23From 2019-10-01
2019-09-30$36.74M-58.4%2021-11-24From 2018-10-01
2018-09-30$88.33M+258.9%2020-11-25From 2017-10-01
2017-09-30$24.61M-20.2%2019-11-27From 2016-10-01
2016-09-30$30.84M-75.2%2018-11-29From 2015-10-01
2015-09-30$124.15M+553.9%2017-12-11From 2014-10-01
2014-09-30$18.98M+110.3%2016-12-09From 2013-10-01
2013-09-30$9.03M-57.6%2015-12-11From 2012-10-01
2012-09-30$21.29M-15.9%2014-12-11From 2011-10-01
2011-09-30$25.30M—2013-12-18From 2010-10-01